Admission CALLY Index and Angiographic No-Reflow After Primary PCI in a Retrospective STEMI Cohort
Journal of Clinical Medicine · 08.11.2026 · 15 (21) · 8724
DOI: 10.3390/jcm15218724 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 08.11.2026. Verfasst von Fahrettin Turna und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sakarya University Training and Research Hospital, Sakarya 54100, Turkey. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The CALLY index draws on three admission tests—C-reactive protein, albumin, and lymphocyte count. We investigated whether it was associated with angiographic no-reflow after primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI).
Methods
We reviewed 1245 patients treated at one center between January 2024 and January 2026. Logistic regression accounted for clinical risk factors, baseline Thrombolysis in Myocardial Infarction (TIMI) flow, culprit artery, thrombus grade 5, Killip class at the start of PCI, and door-to-balloon time. We also tested alternative endpoint definitions, assessed influential observations, and compared correlated receiver operating characteristic (ROC) curves.
Results
No-reflow occurred in 206 patients (16.5%). CALLY was lower in this group than in the reflow group (median 1.11 [0.39–1.92] vs. 1.33 [0.73–2.11]). Each one-unit increase in ln(CALLY) was associated with lower odds of no-reflow after adjustment (odds ratio [OR] 0.800, 95% confidence interval [CI] 0.693–0.923; p = 0.0023). The association remained when the endpoint was limited to impaired final angiographic reperfusion (OR 0.832, 0.717–0.965; p = 0.015). Discrimination by CALLY alone was poor (area under the curve [AUC] 0.578, 0.534–0.623); it was not significantly better than its components or the other indices studied. At a displayed threshold of ≤0.905, positive and negative predictive values were 22.8% and 86.8%. The association weakened after removal of the upper and lower 1% of values (p = 0.063).
Conclusions
Admission CALLY was associated with recorded angiographic no-reflow, even after broader adjustment. Its weak discrimination and small incremental contribution, however, do not support use for individual risk classification without further study.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Sakarya University Training and Research Hospital, Sakarya 54100, Turkey.
- Department of Cardiology, Sakarya University School of Medicine, Sakarya 54100, Turkey.
- Department of Cardiology, Tunceli State Hospital, Tunceli 62000, Turkey.
- Department of Cardiology, Medipol University School of Medicine, İstanbul 34083, Turkey.
ORCID-Profile: Fahrettin Turna, Emre Eynel, Muhammet Taşdemir, Şevval Özdemir, Emirhan Hancıoğlu, Yusuf Can, İbrahim Kocayiğit
Zitieren
APA
Turna, F., Eynel, E., Taşdemir, M., Nyyazov, A., Özdemir, Ş., Yıldız, M. Ş., Hancıoğlu, E., Can, Y., & Kocayiğit, İ. (2026). Admission CALLY Index and Angiographic No-Reflow After Primary PCI in a Retrospective STEMI Cohort. Journal of Clinical Medicine, 15(21), 8724. https://doi.org/10.3390/jcm15218724
Vancouver
Turna F, Eynel E, Taşdemir M, Nyyazov A, Özdemir Ş, Yıldız MŞ, et al. Admission CALLY Index and Angiographic No-Reflow After Primary PCI in a Retrospective STEMI Cohort. Journal of Clinical Medicine. 2026;15(21):8724. doi:10.3390/jcm15218724
BibTeX
@article{Turna2026,
author = {Turna, Fahrettin and Eynel, Emre and Taşdemir, Muhammet and Nyyazov, Arslan and Özdemir, Şevval and Yıldız, Mehmet Şirin and Hancıoğlu, Emirhan and Can, Yusuf and Kocayiğit, İbrahim},
title = {Admission CALLY Index and Angiographic No-Reflow After Primary PCI in a Retrospective STEMI Cohort},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {21},
pages = {8724},
doi = {10.3390/jcm15218724}
}
EUVIMED